STN: BL 125555
Proper Name: Antihemophilic Factor (Recombinant)
Tradename: NUWIQ
Manufacturer: Octapharma USA, Inc.
Indication:
- Indicated in adults and children with Hemophilia A for:
- On-demand treatment and control of bleeding episodes
- Perioperative management of bleeding
- Routine prophylaxis to reduce the frequency of bleeding episodes
